Freeway
Arizona

Tucson

Data as of Oct 1, 2026
715
Companies
$10.0M
Venture funding in the last 12 months, 2 rounds
$94.7M
Venture funding, 2022–2026
32
Investor firms

Venture funding by year

* 2026 through Oct 2026. Rounds without a disclosed amount count as rounds, not dollars.
Show as a table
YearVenture fundingRounds
2019$14.1M12
2020$29.2M11
2021$19.9M11
2022$35.6M9
2023$3.7M7
2024$28.2M11
2025$17.2M6
2026*$10.0M2

Industries

  • Health126
  • Energy46
  • Education37
  • Semiconductors37
  • Fintech34
  • Food30
  • Enterprise software29
  • Real estate26
  • Kids22
  • Security17

And 19 more industries.

Companies in Tucson

625–648 of 715 companies

  • Early stage

  • The Post Workspaces, located in Tucson, AZ, offers dynamic coworking solutions designed to cater to modern professionals seeking flexibility and innovation in their work environment. The company provides fully equipped meeting spaces for gatherings of up to 25 people, as well as flexible workspace options that allow clients to work when, where, and how they prefer. The Post Workspaces serves a diverse clientele, including freelancers, remote workers, small business owners, and corporate teams, who benefit from its state-of-the-art amenities and vibrant professional atmosphere. Operating within the coworking industry, The Post Workspaces generates revenue through membership fees, which grant access to its facilities and services. The business model emphasizes community experience, providing a supportive environment that fosters collaboration and productivity. By prioritizing hospitality and offering essential office space solutions without the physical footprint, The Post Workspaces is redefining the traditional office concept.

    Early stage · 2–10 employees

  • the prime leaf

    Wellness & beauty

    Early stage · 11–50 employees

  • Early stage · 11–50 employees

  • The Terry J. Lundgren Center for Retailing at the University of Arizona's Norton School of Human Ecology is an educational and research institution focused on developing future leaders for the retail industry. In 2005, the center was renamed to honor Terry J. Lundgren, a University of Arizona alumnus and the retired Chairman and CEO of Macy's, Inc., following his substantial financial contributions and active involvement. Lundgren, a 1974 graduate, began his career in 1975 as a trainee at Bullock's, a division of what is now Macy's, Inc. His career included serving as Chairman and CEO of Neiman Marcus before rejoining the parent company of Macy's in 1994, where he eventually led major initiatives, including the acquisition of The May Department Stores Company. His journey from a student paying his own way through college to a top executive in the retail world inspired his significant support for the center. The center serves as a bridge between academia and the retail sector, offering programs, professional development, and hands-on learning opportunities to students. It hosts major events like the Global Retailing Conference, which brings C-suite executives from companies like Walmart, Costco, and PetSmart to interact with students. A key feature is the Lundgren Consumer Science Lab, a state-of-the-art facility equipped with virtual reality, in-store tracking technology, a touchless POS system, and a "Digital Twin" of a retail space for students to test merchandising and operational strategies. The center is supported by corporate partners and operates as a nonprofit entity within the university, funded by philanthropic gifts and industry partnerships to provide its educational programs.

    Early stage · 2–10 employees

  • Early stage

  • Early stage

  • Early stage

  • TheraCea Pharma is a biotechnology startup based in Tucson, Arizona, specializing in the development of innovative diagnostic agents for biomedical imaging, particularly Positron Emission Tomography (PET) products. The company operates in the precision medicine market, which focuses on tailoring medical treatment to the individual characteristics of each patient. TheraCea's primary clients include healthcare providers, research institutions, and pharmaceutical companies that require advanced diagnostic tools to enhance patient care and streamline drug development processes.TheraCea's business model revolves around the research and development (R&D) of novel radiopharmaceuticals—radioactive compounds used in medical imaging to diagnose and monitor diseases. These products are designed to meet stringent regulatory requirements set by the U.S. Food and Drug Administration (FDA). The company generates revenue through the sale of these diagnostic agents to healthcare facilities and through partnerships with pharmaceutical companies engaged in drug development.TheraCea's revenue streams are diversified. They earn money by licensing their proprietary technology to other companies, selling their diagnostic agents directly to medical institutions, and forming strategic alliances with pharmaceutical firms for co-development projects. Additionally, they may receive grants and funding from government agencies and private investors interested in advancing precision medicine.The company is committed to innovation and regulatory compliance, employing a team of experts in life sciences, clinical sciences, public health, and engineering. They also offer internship opportunities to students and professionals eager to gain hands-on experience in the radiopharmaceutical drug development process, including understanding FDA guidelines and regulatory submissions.

    Early stage · 2–10 employees · $260K raised

  • Theratrics is a leading provider of healthcare services dedicated to transforming healthcare and improving lives. The company focuses on delivering innovative solutions that empower individuals to live healthier lives and achieve their full potential. Theratrics operates in the healthcare market, serving a diverse range of clients including individuals, families, and healthcare providers. The business model revolves around offering comprehensive healthcare coverage, professional development opportunities, and wellness programs. Revenue is generated through healthcare plans, retirement savings programs, and employer matching contributions. Theratrics prioritizes employee well-being with top-tier medical, dental, and vision plans, flexible work arrangements, and ongoing training and development programs. The company is committed to fostering a collaborative, innovative, and compassionate work environment.

    Early stage · 1 employees · $260K raised

  • Early stage

  • ThinkShare

    Education

    Early stage

  • Early stage

  • TIPD

    Semiconductors

    The company develops and manufactures optoelectronic devices, subsystems, and volume holographic optical elements (VHOEs) for defense, aerospace, sensing, and display applications. Its portfolio includes compact high-power ultraviolet and infrared lasers, Raman amplifiers, holographic displays and HOEs, and specialized optical windows and beam-director components. TIPD maintains purpose-built laboratory space in Tucson suitable for ITAR-restricted work and has also operated display and holographic processing facilities in Oceanside, California. The firm's business model centers on SBIR/STTR and other federal R&D contracts with the Navy, Army, NASA, and related agencies, while licensing and partnering on near-to-eye and 3-D holographic display technologies.

    Early stage · 2–10 employees · $2.7M raised

  • Breakout · 51–200 employees

  • Early stage

  • Top Electronicsusa

    Robotics, Semiconductors

    Early stage · 2–10 employees

  • Early stage

  • Early stage

  • Early stage · 11–50 employees

  • Early stage

  • Breakout · 51–200 employees

  • Transtek Magnetics

    Energy, Semiconductors

    Early stage · 11–50 employees

  • Early stage · 1 employees

Recent venture rounds

CompanyRoundAmountDateInvestors
World View EnterprisesLate VC$10.0MMar 2026Ondas Holdings
KeysEarly VCUndisclosedMar 2026Not disclosed
Revolute RoboticsSeed$1.9MOct 2025ANIMO Ventures, Ascend VC
Delta Development TeamSeries AUndisclosedAug 2025Pasadena Angels, Desert Angels, Central Texas Angel Network +3 more
TYBSeries A$11.0MJun 2025Coinbase Ventures, Unusual Ventures, Castle Island Ventures +2 more
T&R Recovery GroupGrowth Equity VCUndisclosedJun 2025Cyprium Investment Partners, Genesis Park
Branch TherapeuticsSeed$4.0MMay 2025GKCC
SorbiforceSeed$270KApr 2025StartEngine
Precision EpigenomicsSeries A$1.5MSep 2024Shaffer Capital
World View EnterprisesLate VC$25.0MMay 2024Breakthrough Victoria
Investors based here
Accelerators and programs

Source: Dealroom, data as of Oct 1, 2026. Venture funding sums venture-type rounds with a disclosed amount; rounds raised by companies already public or bought out are left out. The last 12 months run from Nov 2025 to Oct 2026.

Founders, team members and individual investors are never shown, and company descriptions have sentences naming people removed.